Biomarkers identified as potential factors associated with the development of metabolic disorders such as type 2 diabetes and obesity, namely GLP-1, GIP, MCP-1, and IGFBP-7, have been the subject of extensive scientific research. Here, CCL2 is linked to metabolic disease.